Drug Shortage Report for METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION
| Report ID | 1724 |
| Drug Identification Number | 02231893 |
| Brand name | METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION |
| Common or Proper name | METHYLPREDNISOLONE |
| Company Name | TEVA CANADA LIMITED |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | METHYLPREDNISOLONE |
| Strength(s) | 40MG |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAMUSCULAR INTRAVENOUS |
| Packaging size | 10 |
| ATC code | H02AB |
| ATC description | CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2016-02-29 |
| Estimated end date | 2022-12-01 |
| Actual end date | 2021-09-10 |
| Shortage status | Resolved |
| Updated date | 2021-09-23 |
| Company comments | Item is discontinued. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2021-09-23 | French | Compare |
| v5 | 2021-09-23 | English | Compare |
| v4 | 2020-02-13 | French | Compare |
| v3 | 2020-02-13 | English | Compare |
| v2 | 2017-03-13 | French | Compare |
| v1 | 2017-03-13 | English | Compare |
Showing 1 to 6 of 6